Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Lew

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Archives of Neurology|August 26, 1998
Randomized, placebo-controlled study of tolcapone in patients with fluctuating Parkinson disease treated with levodopa-carbidopa. Tolcapone Fluctuator Study Group IIIC H Adler, C Singer, C O'Brien, et al.
Neurology|October 26, 1999
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystoniaM F Brin, M F Lew, C H Adler, et al.
Neurology|October 26, 1999
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystoniaA Brashear, M F Lew, D D Dykstra, et al.
Neurology|September 26, 1997
Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystoniaM F Lew, B T Adornato, D D Duane, et al.
Neurology|September 26, 2001
Genome-wide scan for Parkinson's disease: the GenePD StudyA L DeStefano, L I Golbe, M H Mark, et al.
Neurology|December 28, 2006
Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD StudyJ B Wilk, J E Tobin, O Suchowersky, et al.
Neurology|May 30, 2008
Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD StudyJ E Tobin, J C Latourelle, M F Lew, et al.
Neurology|February 27, 2001
A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's diseaseI Shoulson, J Penney, M McDermott, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Archives of Neurology|August 26, 1998
Randomized, placebo-controlled study of tolcapone in patients with fluctuating Parkinson disease treated with levodopa-carbidopa. Tolcapone Fluctuator Study Group IIIC H Adler, C Singer, C O'Brien, et al.
Neurology|October 26, 1999
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystoniaM F Brin, M F Lew, C H Adler, et al.
Neurology|October 26, 1999
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystoniaA Brashear, M F Lew, D D Dykstra, et al.
Neurology|September 26, 1997
Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystoniaM F Lew, B T Adornato, D D Duane, et al.
Neurology|September 26, 2001
Genome-wide scan for Parkinson's disease: the GenePD StudyA L DeStefano, L I Golbe, M H Mark, et al.
Neurology|December 28, 2006
Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD StudyJ B Wilk, J E Tobin, O Suchowersky, et al.
Neurology|May 30, 2008
Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD StudyJ E Tobin, J C Latourelle, M F Lew, et al.
Neurology|February 27, 2001
A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's diseaseI Shoulson, J Penney, M McDermott, et al.
Pageof 2